UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
TGFβ2-mediated epithelial-mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance Journal article
Acta Pharmacologica Sinica, 2020,Page: 451-459
Authors:  Jiang, XM;  Xu, YL;  Yuan, LW;  Zhang, LL;  Huang, MY;  Ye, ZH;  Su, MX;  Chen, X. P.;  Zhu, H;  Ye, R;  Lu, J.
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/08/26
EGFR mutant non-small cell lung cancer  NF-κB  TGFβ2  epithelial-mesenchymal transition  osimertinib resistance  
Simultaneous quantification six active compounds in rat plasma by UPLC–MS/MS and its application to a pharmacokinetic study of Pien-Tze- Huang Journal article
Journal of Chromatography B, 2017,Page: 314-321
Authors:  Xu, W;  Zhang, YP;  Zhou, CJ;  Tai, YN;  Zhang, XQ;  Liu, J;  Sha, M;  Huang, MQ;  Zhu, YL;  Peng, J;  Lu, J.
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/03/31
Pian-Tze-Huang  UPLC–MS/MS  Ginsenosides  Muscone  Pharmacokinetics